Nab-paclitaxel Clinical Trials

7 clinical trials for Nab-paclitaxel across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study — RECRUITING · PHASE2
• Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer — RECRUITING · PHASE2
• Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer — RECRUITING · PHASE2
• Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer — RECRUITING · PHASE2
• Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC — RECRUITING · PHASE2
• Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer — RECRUITING · PHASE2
• Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas — OTHER · PHASE2

Refine this search